Mergers & Acquisitions - Biotechnology


Current filters:


Popular Filters

176 to 200 of 266 results

Geron signs tentative deal with BioTime on stem cell assets


A year after announcing its decision to exit stem cell therapy, the USA's Geron Corp (Nasdaq: GERN) has…

BiotechnologyBioTimeFinancialGeron CorpMergers & Acquisitions

Synthetic Biologics to acquire clinical-stage C. diff infectious disease program


USA-based Synthetic Biologics (NYSE: SYN), a developer of synthetic biologics and innovative medicines…

Antibiotics and Infectious diseasesBiotechnologyMergers & AcquisitionsPrev AbRSYN-004Synthetic Biologics

Almirall expands in personalized medicine with 5% equity stake in AB-Biotics


Spain's largest pharma company Almirall (ALM.MC) says it has reached an agreement with the Spanish biotech…

AB-BioticsAlmirallBiotechnologyMergers & AcquisitionsPharmaceuticalResearch

Pharmaceutical M&A activity declining slightly, reports Irving Levin Associates


A new five-and-a-half year pharmaceutical merger and acquisition report published by Irving Levin Associates…

BiotechnologyMergers & AcquisitionsPharmaceutical

Celgene in deal with PharmAria, including an acquisition option


Recently-formed drug discovery company PharmAria has entered into an agreement with US biotech firm Celgene…

BiotechnologyCelgeneMergers & AcquisitionsOncologyPharmAriaResearch

Australia's Benitec to acquire US RNAi firm Tacere


Australia-based Benitec Biopharma (ASX: BLT) said last Friday that it has executed an agreement to acquire…

Anti-viralsBenitec BiopharmaBiotechnologyMergers & AcquisitionsPharmaceuticalTacere Therapeutics

Optimer Pharma to sell remaining stake in Optimer Biotech for $60 million


San Diego, USA-based Optimer Pharmaceuticals (Nasdaq: OPTR) yesterday announced the sale of its stake…

BiotechnologyDificidMergers & AcquisitionsOptimer BiotechnologyOptimer PharmaceuticalsPharmaceutical

French drugmaker Aguettant takes majority stake in PX'Therapeutics


Aguettant Sante, a French biotechnology pioneer in drugs for injection since 1903, has acquired a majority…

AguettantBiotechnologyMergers & AcquisitionsPX'Therapeutics

Achillion Pharma moves up as a contender in the HCV market, GlobalData believes


On September 27, Achillion Pharmaceuticals (Nasdaq: ACHN) released news of positive results surrounding…

ACH-3102Achillion PharmaceuticalsAnti-viralsBiotechnologyMergers & AcquisitionsPharmaceuticalResearch

Russia's Maxwell Biotech Venture Fund invests in Osteros Biomedica


Earlier this month, the investment committee of Maxwell Biotech Venture Fund (MBVF), founded with the…

BiotechnologyMaxwell BiotechMBC PharmaMBC-11Mergers & AcquisitionsOncologyOsteros BiomedicaResearch

China's BGI-Shenzhen to acquire Complete Genomics; Mitsui ups stake in Arch Pharmalabs


Complete Genomics (Nasdaq: GNOM) yesterday revealed that it has entered into a definitive merger agreement…

Arch PharmalabsBGI-ShenzhenBiotechnologyComplete GenomicsGenericsMergers & AcquisitionsMitsui & Co

Bionomics buys US cancer stem cell firm Eclipse Therapeutics


Australian biotech firm Bionomics (ASX: BNO) has expanded its presence in the USA with the acquisition…

BionomicsBiotechnologyEclipse TherapeuticsMergers & AcquisitionsOncology

M&A briefs: GlaxoSmithKline/Response Genetics; Bayer/Teva unit


USA-based Response Genetics (Nasdaq: RGDX) last week entered into a purchase agreement with UK pharma…

BayerBiotechnologyFinancialGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalResponse GeneticsTeva Pharmaceutical Industries

Lundbeck takes 5% stake in Biotie; amends Selincro licensing deal


Danish CNS drug specialist Lundbeck A/S (LUND: DC) said this morning that it has made an investment of…

BiotechnologyBiotie TherapiesFinancialLicensingLundbeckMergers & AcquisitionsNeurologicalPharmaceuticalSelincro

Synergy Pharma gains rights to shingles drug from Bristol-Myers


US biopharma firm Synergy Pharmaceuticals (Nasdaq: SGYP) has signed an asset purchase agreement with…

Anti-viralsBiotechnologyBristol-Myers SquibbFV-100Mergers & AcquisitionsSynergy Pharmaceuticals

Cortex and Pier Pharma in all-share merger


USA-based neuroscience company Cortex Pharmaceuticals (OTCBB: CORX) and privately held biotech firm Pier…

BiotechnologyCortex PharmaceuticalsMergers & AcquisitionsNeurologicalPharmaceuticalPier Pharmaceuticals

MEI Pharma to acquire S*BIO's pracinostat


US cancer drug developer MEI Pharma (Nasdaq: MEIP) has entered into a definitive asset purchase agreement…

BiotechnologyMEI PharmaMergers & AcquisitionsOncologyPharmaceuticalpracinostatS*BIO

US FDA clears Amarin's Vascepa, a competitor for Lovaza


The US Food and Drug Administration has approved biotech firm Amarin's (Nasdaq: AMRN) Vascepa (icosapent…

AmarinBiotechnologyCardio-vascularGlaxoSmithKlineLovazaMergers & AcquisitionsNorth AmericaRegulationVascepa

Synergy Pharma and Callisto enter merger accord


USA-based biopharma groups Synergy Pharmaceuticals (Nasdaq: SGYP) and Callisto Pharmaceuticals (OTCBB:…

BiotechnologyCallisto PharmaceuticalsMergers & AcquisitionsSynergy Pharmaceuticals

176 to 200 of 266 results

Back to top